Updated September 2026

The Peptide
Benchmark

Independent vendor rankings, peptide price comparison, and evidence-graded research profiles in one place. Source-linked data, not vague claims.

397
Vendors Ranked
8,601
Prices Tracked
137
Peptide Profiles
Daily
Refreshed

Vendor Rankings

Vendors ranked by PeptideBenchmark's own scoring model — combining trust evidence, pricing coverage, and third-party review data from Finnrick, Peptide Critic, and Trustpilot.

Vendors Ranked
397

Vendors with enough evidence to earn a score on the board.

Trust Reviewed
113

Curated vendors with pricing, COA evidence, and transparency assessment.

Trustpilot Tracked
27

Vendors with live Trustpilot scores integrated into rankings.

How scoring works

Each vendor's rank score reflects our own evidence: COA coverage, pricing depth, and third-party trust signals from Trustpilot, Finnrick, and Peptide Critic. External sources contribute as bonus signals, not gatekeepers — a vendor with strong PeptideBenchmark evidence can rank without them.

Open full benchmark board
View All Vendor Reviews →

Peptide Price Comparison

Live pricing across 113 curated vendors, normalized by total milligrams. Affiliate coupon codes applied automatically so you see the effective price, not just the sticker price.

113
Vendors tracked
Daily
Price refresh
20%
Max coupon discount
Compare pricesBrowse coupon codes
Public evidence infrastructureNew

Search the certificate, not the claim.

Find source-linked peptide certificates by vendor, compound, laboratory, batch, tested panel, and verification status.

Explore the COA database

How the vendor and testing layers fit together

Start here if you want the shortest path through the site’s trust architecture. The vendor side shows who exposes transparency well, the testing side shows which labs and platforms anchor that evidence, and the bridge shows where those stories actually meet.

Start here for public verification
Janoshik

Start here if you care most about public report verification that ordinary readers can inspect themselves.

Start here for direct consumer flow
Kovera

Good fit when you want a more direct-consumer testing flow with visible pricing and shareable verification behavior.

Start here for classic lab profiles
Freedom / ILS

Better fit when you want classic analytical-lab framing instead of a platform-style public results experience.

Open vendor compareOpen testing compareOpen bridge viewBrowse testing directory

Peptides by research area

Explore compounds organized by research area — metabolic, tissue-repair, GH axis, and more — with regulatory context and evidence notes on each profile.

🧪
Hormone signaling research
42 profiles
Hormone-linked signaling compounds that do not fit cleanly into the GH or metabolic buckets.
⚖️
Metabolic / incretin research
23 profiles
GLP-1 agonists, dual agonists, triple agonists, and related metabolic signaling compounds.
🩹
Tissue-repair research
21 profiles
Tissue-repair, soft-tissue, and gut-oriented peptides commonly discussed in regenerative research contexts.
Longevity
19 profiles
Research-area coverage will expand here as more profiles are published.
Other research areas
19 profiles
Useful overflow for compounds that do not belong to the main editorial buckets.
💪
Performance / anabolic research
18 profiles
Performance-adjacent peptides and growth-factor analogs that usually sit outside labeled medical use.
🛡️
Immune / inflammation research
17 profiles
Immune-oriented peptides with more clinical framing than the average research-market profile.
Dermal / cosmetic research
16 profiles
Copper peptides, regenerative signaling compounds, and dermal-facing entries with cosmetic crossover.
🧬
Longevity research
15 profiles
Longevity-facing compounds where mechanism, speculation, and marketing often collide.
Metabolic
15 profiles
Research-area coverage will expand here as more profiles are published.
Neuroprotection
15 profiles
Research-area coverage will expand here as more profiles are published.
📈
GH axis / secretagogue research
13 profiles
GHRH analogs and secretagogues studied in the growth-hormone axis literature.
🧠
Cognitive / nootropic research
13 profiles
Cognitive and neuropeptide-oriented compounds that are popular online but often weakly explained.
Cardiovascular
10 profiles
Research-area coverage will expand here as more profiles are published.

Trending Peptides

Current profile coverage pulled directly from the peptide collection, mixing FDA-approved medicines with closely watched research compounds.

🔥 HOT
Metabolic
Retatrutide
A next-generation triple agonist targeting GLP-1, GIP, and glucagon receptors, showing unprecedented 24.2% weight loss in clinical trials. Expected FDA approval in 2027.
Investigational1 alias
Trials 35PubMed 180Medium context
Triple AgonistPhase 3GLP-1GIP
🔥 HOT
Metabolic
Semaglutide
A GLP-1 receptor agonist used in FDA-approved products for type 2 diabetes, chronic weight management, and additional labeled uses depending on brand and indication.
FDA Approved3 aliases
FDATrials 779PubMed 5.5KHigh context
GLP-1FDA ApprovedWeight ManagementType 2 Diabetes
🔥 HOT
Metabolic
Tirzepatide
A dual GIP and GLP-1 receptor agonist used in FDA-approved products for type 2 diabetes and chronic weight management.
FDA Approved2 aliases
FDATrials 299PubMed 2.5KHigh context
GIPGLP-1FDA ApprovedWeight Management
Tissue repair
BPC-157
A 15-amino acid peptide derived from human gastric juice, extensively studied for tissue regeneration, gut healing, and injury recovery across multiple systems.
Research Market2 aliases
Also in Performance
Trials 4PubMed 222Medium context
HealingGut HealthTendon RepairRecovery
🔥 HOT
Metabolic
CagriSema
A Novo Nordisk investigational combination of cagrilintide and semaglutide, designed to pair amylin and GLP-1 pathways in obesity.
Investigational
Also in Hormone
Trials 30PubMed 54Medium context
CagrilintideSemaglutideAmylinGLP-1
GH axis
Tesamorelin
A growth hormone-releasing hormone analog approved in the United States for reducing excess abdominal fat in certain adults with HIV-associated lipodystrophy.
FDA Approved2 aliases
Also in Performance
FDATrials 24PubMed 94High context
GHRHFDA ApprovedBody CompositionHIV Lipodystrophy

From the Blog

Collection-backed notes on benchmark methodology, source quality, and how to interpret peptide vendor signal without overclaiming certainty.

View All Posts →